Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury

Critical Care Medicine

Volumn 39, Issue 6, 2011, Pages 1454-1460

  Fisher, Bernard J ^a   Seropian, Ignacio M ^a   Kraskauskas, Donatas ^a   Thakkar, Jay N ^b   Voelkel, Norbert F ^a   Fowler, Alpha A ^a   Natarajan, Ramesh ^a  

^a Department of Internal Medicine   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

ascorbic acid; dehydroascorbic acid; inflammation; lipopolysaccharide; lung injury; nuclear factor kappa B

Indexed keywords

ASCORBIC ACID; CHEMOKINE; DEHYDROASCORBIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG HEMORRHAGE; MALE; MICROTHROMBUS; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SURVIVAL; THROMBOSIS;

EID: 79957646019     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182120cb8     Document Type: Article

References (42)

1. Bone RC, Grodzin CJ, Balk RA: Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997; 112:235-243. (Pubitemid 27343624)
2. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554. (Pubitemid 36437931)
3. Repine JE: Scientific perspectives on adult respiratory distress syndrome. Lancet 1992; 339:466-469.
4. Baetz D, Shaw J, Kirshenbaum LA: Nuclear factor-kappaB decoys suppress endotoxininduced lung injury. Mol Pharmacol 2005; 67:977-979. (Pubitemid 40410398)
5. Bombeli T, Mueller M, Haeberli A: Anticoagulant properties of the vascular endothelium. Thromb Haemost 1997; 77:408-423. (Pubitemid 27121001)
6. Mackman N: Regulation of the tissue factor gene. Thromb Haemost 1997; 78:747-754.
7. Dempfle CE: Coagulopathy of sepsis. Thromb Haemost 2004; 91:213-224.
8. Nishikimi M, Fukuyama R, Minoshima S, et al. Cloning and chromosomal mapping of the human nonfunctional gene for L-gulonogamma- lactone oxidase, the enzyme for Lascorbic acid biosynthesis missing in man. J Biol Chem 1994; 269:13685-13688.
9. Vera JC, Rivas CI, Fischbarg J, et al. Mammalian facilitative hexose transporters medi- ate the transport of dehydroascorbic acid. Nature 1993; 364:79-82. (Pubitemid 23233461)
10. Vera JC, Rivas CI, Velásquez FV, et al. Resolution of the facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid. J Biol Chem 1995; 270:23706-23712.
11. Levine M, Wang Y, Padayatty SJ, et al. A new recommended dietary allowance of vitamin C for healthy young women. Proc Nat Acad Sci USA 2001; 98:9842-9846. (Pubitemid 32769391)
12. Wilson JX: Mechanism of action of vitamin C in sepsis: Ascorbate modulates redox signaling in endothelium. Biofactors 2009; 35: 5-13.
13. Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24:392-397. (Pubitemid 26097830)
14. Galley HF, Davies MJ, Webster NR: Ascorbyl radical formation in patients with sepsis: Effect of ascorbate loading. Free Radic Biol Med 1996; 20:139-143. (Pubitemid 26014329)
15. Ades EW, Candal FJ, Swerlick RA, et al. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992; 99:683-690. (Pubitemid 23002027)
16. Ockaili R, Natarajan R, Salloum F, et al. HIF-1 activation attenuates postischemic myocardial injury: Role for heme oxygenase- 1 in modulating microvascular chemokine generation. Am J Physiol Heart Circ Physiol 2005; 289:H542-H548. (Pubitemid 41129367)
17. Natarajan R, Salloum FN, Fisher BJ, et al. Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium. Am J Physiol Heart Circ Physiol 2007; 293:H1571-H1580. (Pubitemid 47367202)
18. Cárcamo JM, Pedraza A, Bórquez-Ojeda O, et al. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation. Biochemistry 2002; 41:12995-13002. (Pubitemid 35215783)
19. Bergsten P, Amitai G, Kehrl J, et al. Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes. Depletion and reaccumulation. J Biol Chem 1990; 265: 2584-2587.
20. Butler JD, Bergsten P, Welch RW, et al. Ascorbic acid accumulation in human skin fibroblasts. Am J Clin Nutr 1991; 54: 1144S-1146S.
21. Chatterjee A, Dimitropoulou C, Drakopanayiotakis F, et al. Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis. Am J Respir Crit Care Med 2007; 176:667-675. (Pubitemid 47503074)
22. Cai L, Koropatnick J, Cherian MG: Roles of vitamin C in radiation-induced DNA damage in presence and absence of copper. Chem Biol Interact 2001; 137:75-88. (Pubitemid 32772762)
23. Clément MV, Ramalingam J, Long LH, et al. The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide. Antioxid Redox Signal 2001; 3:157-163. (Pubitemid 32241828)
24. Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury: Summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2003; 167:1027-1035. (Pubitemid 36408170)
25. Cohen J: The immunopathogenesis of sepsis. Nature 2002; 420:885-891. (Pubitemid 36019643)
26. Abraham E, Singer M: Mechanisms of sepsisinduced organ dysfunction. Crit Care Med 2007; 35:2408-2416.
27. Abraham E: Nuclear factor-kappaB and its role in sepsis-associated organ failure. J Infect Dis 2003; 187:S364-S369. (Pubitemid 36724510)
28. Rao RM, Yang L, Garcia-Cardena G, et al. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res 2007; 101:234-247. (Pubitemid 47344073)
29. Cárcamo JM, Pedraza A, Bórquez-Ojeda O, et al. Vitamin C is a kinase inhibitor: Dehydroascorbic acid inhibits IkappaBalpha kinase beta. Mol Cell Biol 2004; 24:6645-6652. (Pubitemid 38944344)
30. Knowles HJ, Raval RR, Harris AL, et al. Effect of ascorbate on the activity of hypoxiainducible factor in cancer cells. Cancer Res 2003; 63:1764-1768. (Pubitemid 36460834)
31. Jones DT, Trowbridge IS, Harris AL: Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate. Cancer Res 2006; 66: 2749-2756.
32. Wilson JX: Regulation of vitamin C transport. Annu Rev Nutr 2005; 25:105-125. (Pubitemid 41208996)
33. Guaiquil VH, Vera JC, Golde DW: Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL-60 cells. J Biol Chem 2001; 276: 40955-40961.
34. Lutsenko EA, Cárcamo JM, Golde DW: Vitamin C prevents DNA mutation induced by oxidative stress. J Biol Chem 2002; 277: 16895-16899 (Erratum, 277:27576.). (Pubitemid 34967715)
35. Armour J, Tyml K, Lidington D, et al. Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. J Appl Physiol 2001; 90:795-803. (Pubitemid 32171360)
36. Kim JY, Lee SM: Vitamins C and E protect hepatic cytochrome P450 dysfunction induced by polymicrobial sepsis. Eur J Pharmacol 2006; 534:202-209.
37. Tyml K, Li F, Wilson JX: Septic impairment of capillary blood flow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism. Crit Care Med 2008; 36:2355-2362.
38. Gaut JP, Belaaouaj A, Byun J, et al. Vitamin C fails to protect amino acids and lipids from oxidation during acute inflammation. Free Radic Biol Med 2006; 40:1494-1501.
39. Chen Q, Espey MG, Sun AY, et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Nat Acad Sci USA 2008; 105:11105-11109.
40. Lowes DA, Webster NR, Galley HF: Dehydroascorbic acid as pre-conditioner: Protection from lipopolysaccharide induced mitochondrial damage. Free Radic Res 2010; 44: 283-292.
41. Lehr HA, Germann G, McGregor GP, et al. Consensus meeting on "Relevance of parenteral vitamin C in acute endothelial dependent pathophysiological conditions (EDPC)." Eur J Med Res 2006; 11:516-526. (Pubitemid 46040282)
42. Tyml K, Li F, Wilson JX: Delayed ascorbate bolus protects against maldistribution of microvascular blood flow in septic rat skeletal muscle. Crit Care Med 2005; 33:1823-1828 (Pubitemid 41153709)